Newzen Pharma is a U.S.-based generic medicine manufacturing and clinical-stage biotechnology company focused on pioneering the development by targeting DNA repair within cancer/tumor cells. The company is recognized by the US Food and Drug Administration (FDA) and aims to escalate its business in Research and Development for drug formulation and manufacturing. Newzen Pharma's vision is to deliver cost-efficient medicines of the highest quality to pharmacies and hospitals in the US, Africa, and Asia. They have developed compositions and methods for treating prostate cancer by targeting DNA repair within cancer cells, inhibiting BER capacity without compromising normal cell growth.